SA’s medicines regulator has confirmed that one of the conditions attached to its approval of Johnson & Johnson’s (J&J)  Covid-19 vaccine restricts its sale to the national government, Business Day has learnt. 

This means that neither provincial governments nor private-sector entities, such as large employers or pharmacies, can buy directly from the vaccine manufacturer, even if it were willing to sell directly to them. J&J and several other vaccine manufacturers have previously indicated they will only sell to the national, but private-sector players have been hopeful that this position will shift at some point...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now